International Stem Cell Corporation (OTC:ISCO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles J. Casamento Other companies: GT Biopharma, Inc. (Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); Relmada Therapeutics, Inc. (Chairman of the Board · Since at least Oct 20, 2017); PaxMedica, Inc. (Director · Oct 1, 2022 – Mar 12, 2024 · Past); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past) | Director · Mar 31, 2016 – Jun 21, 2018 · Past |
| Paul V. Maier Other companies: Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least May 3, 2021); Ambrx Biopharma Inc. (Director · Jan 1, 2023 – Mar 7, 2024 · Past) | Director · Since at least Jun 9, 2021 |
| Edward O Hunter Other companies: GEE Group Inc. (Director · Feb 23, 2009 – Feb 23, 2009 · Past) | Director · Jul 19, 2007 – Dec 29, 2008 · Past |
| James H Berglund Other companies: Accredited Home Lenders Holding Co (Director · Oct 12, 2007 – Oct 12, 2007 · Past) | Director · Mar 9, 2012 – Jun 20, 2013 · Past |
| Andrey Semechkin | Chief Executive Officer & Co-Chairman of the Board · Since at least Apr 25, 2022 |
| Donald Wright | Co-Chairman · Since at least Nov 5, 2026 |
| Mahnaz Ebrahimi | Chief Financial Officer · May 17, 2016 – May 31, 2017 · Past |
| Russell Kern | Executive Vice President, Chief Scientific Officer & Principal Financial Officer · Since at least Jun 9, 2021 |
| Sophia Garnette | VP, Legal Affairs & Operations · Aug 4, 2014 – Jun 9, 2021 · Past |
| Wright Don | Director · Since at least Dec 29, 2008 |